Overview
Michael Terao, MD, MEd, is a bone marrow transplant hospitalist at Children’s National Hospital and also works as the assistant dean for student learning at the Georgetown University School of Medicine. He received his Bachelor of Arts in English at Allegheny College in Meadville, PA. Dr. Terao graduated from Eastern Virginia Medical School and completed a pediatric residency at UCSF Benioff Children’s Hospital Oakland. After completing residency, he served as pediatric chief resident at the Morehouse School of Medicine Pediatric Residency. He then completed pediatric hematology/oncology fellowship at St. Jude Children's Research Hospital. Dr. Terao also received his Master of Education in the health professions from the Johns Hopkins University. As a cancer survivor himself, Dr. Terao strongly believes in the importance of delivering clinical care that is of the highest quality possible while also being compassionate and empathetic. Dr. Terao has published multiple peer-reviewed manuscripts with his research interests focusing on how to best support learners in medical education who struggle with multiple choice question examinations. Dr. Terao is board certified in general pediatrics and pediatric hematology/oncology.
Dr. Terao is board certified in Pediatrics: American Board Of Pediatrics, 2016 and Pediatric Hematology-Oncology: American Board Of Pediatrics, 2021. He is actively involved in clinical research, co-authoring 12 peer reviewed articles.
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
Locations
111 Michigan Avenue Northwest, Washington, DC 20010
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Main Hospital-Cancer And Blood Disorders Clinic
Holly Meany, MD, is a pediatric oncologist and director of the Solid Tumor Program at Children’s National Hospital. She also serves as an associate professor of pediatrics at George Washington University. Dr. Meany is dedicated to finding better treatments for children with cancer through research and clinical care. Her work focuses on developing new therapies for pediatric solid tumors. She designs and leads early-phase clinical trials to test promising treatments and understand how they work in children. Dr. Meany has played a key role in several national studies, including large trials for neuroblastoma, a type of childhood cancer. She recently led an international study for children with newly diagnosed non-high-risk neuroblastoma and is currently helping to develop the next high-risk neuroblastoma trial, both through the Children’s Oncology Group. Dr. Meany is also exploring innovative approaches like immunotherapy—using the body’s own immune system to fight cancer. She has led international studies using specialized T cells to treat patients with relapsed solid tumors and is now working on combining these novel T cells with CAR T-cell therapy for children with relapsed cancers. In addition to her research, Dr. Meany is passionate about training the next generation of pediatric cancer specialists. As director of the Pediatric Hematology-Oncology Fellowship Program at Children’s National, she mentors and supports future leaders in the field. Dr. Meany is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Hereditary Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Osteosarcoma, and Mastoidectomy. Dr. Meany is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2006 and Pediatrics: American Board Of Pediatrics, 2003.
Main Hospital
Urania Dagalakis, MD, MHSc, specializes in pediatric oncology and hematology. She completed her clinical training at Johns Hopkins University and conducted her research work within the National Cancer Institute of the National Institutes of Health. Due to her research background she specializes in caring for children with rare tumors and hereditary cancer syndromes. Dr. Dagalakis is the director of the Cancer Genetics Clinic at Children’s National Hospital. She is also an assistant professor of pediatrics at The George Washington University School of Medicine and Health Sciences and a physician in the Center for Cancer and Blood Disorders. She is committed to empowering families with knowledge, supporting survivorship and leading innovations in personalized cancer care. Her work bridges compassionate patient care with clinical research focused on improving outcomes for children with genetic cancer predispositions. Dr. Dagalakis is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Hemoglobin SC Disease and Immune Thrombocytopenic Purpura (ITP). Dr. Dagalakis is board certified in Pediatrics: American Board Of Pediatrics, 2023.
Main Hospital-Cancer And Blood Disorders Clinic
Shelby Smith is a Pediatric Hematologist Oncology specialist and a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Smith is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL). Dr. Smith is board certified in Pediatric Nursing Certification Board, 2016.
Main Hospital
Lea Mayer is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. Dr. Mayer is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Hereditary Neuroblastoma, Neuroblastoma, Ewing Sarcoma, and Osteosarcoma. Dr. Mayer is board certified in Oncology Nursing Certification Corporation, 2015 and Primary Care Certified Pediatric Nurse Practitioner (CPNP-PC): Pediatric Nursing Certification Board, 2010.
Luca Szalontay is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. Dr. Szalontay is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Glioma, Diffuse Midline Glioma H3 K27M-Mutant, Medulloblastoma, and Brain Stem Cancer. Dr. Szalontay is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2021 and Pediatrics: American Board Of Pediatrics, 2015. Dr. Szalontay is currently accepting new patients.
Main Hospital-Cancer And Blood Disorders Clinic
Hyojeong Han is a Pediatric Hematologist Oncology specialist and a Transfusion Medicine provider practicing medicine in Washington, Washington, D.c.. Dr. Han is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Anemia, and Hemolytic Anemia. Dr. Han is board certified in American Board Of Pathology, 2021, American Board Of Pediatrics, 2021, and American Board Of Pediatrics, 2016. Dr. Han is currently accepting new patients.
Frequently Asked Questions about Dr. Michael A. Terao
How do I make an appointment with Dr. Michael A. Terao?
You can book an appointment with Dr. Michael A. Terao by calling their office at 888-884-2327. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Does Dr. Michael A. Terao accept my insurance?
Dr. Michael A. Terao accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 888-884-2327 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
We do not have enough information to identify the Areas of Expertise for this provider.